Abstract
The importance of cytochrome P450 enzymes to the Phase I metabolism of drugs and other xenobiotics is reviewed in the light of current knowledge. The relatively new technologies of molecular biology, protein crystallography and molecular modelling have been applied to these enzymes and this endeavour is proving extremely useful for novel compound development.